Vimarsana
Biggest News Aggregation in the World

Boro Dropuli News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Boro Dropuli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Boro Dropuli Today - Breaking & Trending Today

Brazil and Caring Cross to Produce Affordable CAR-T, Stem Cell Gene Therapies - Vimarsana News

Brazil and Caring Cross to Produce Affordable CAR-T, Stem Cell Gene Therapies

Brazil’s Ministry of Health and nonprofit Caring Cross announced a collaboration Tuesday aimed at local manufacturing of CAR-T cell and stem cell gene therapies at a much lower cost than Europe and the U.S.

AmplifyBio and Vector BioMed Partner to Manufacture Plasmids and Share ... - Vimarsana News

AmplifyBio and Vector BioMed Partner to Manufacture Plasmids and Share ...

AmplifyBio and Vector BioMed Partner to Manufacture Plasmids and Share ...

Vector BioMed Selected as Preferred Lentiviral Vector Manufacturing Partner for California Institute for Regenerative Medicine - Vimarsana News

Vector BioMed Selected as Preferred Lentiviral Vector Manufacturing Partner for California Institute for Regenerative Medicine

/PRNewswire/ -- Vector BioMed, a biomanufacturing company specializing in the manufacture of lentiviral vectors, today announced an agreement with the...

Vector BioMed Appoints Jakob Reiser, Ph.D., as Senior Director of Regulatory Affairs - Vimarsana News

Vector BioMed Appoints Jakob Reiser, Ph.D., as Senior Director of Regulatory Affairs

/PRNewswire/ -- Vector BioMed, a biomanufacturing company specializing in the manufacture of lentiviral vectors, today announced the appointment of Jakob...

Cell Therapy Pioneers Team Up to Found Viral Vector CDMO Backed by $64M - Vimarsana News

Cell Therapy Pioneers Team Up to Found Viral Vector CDMO Backed by $64M

VintaBio manufactures AAV and lentiviral vectors for entities pursuing clinical development of cell and gene therapies. The contract development manufacturing organization’s launch comes as demand for viral vectors continues to outpace the supply of these crucial components of the therapies.